H.R. 6294 · 115th Congress
REVAMP Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
ShimkusSponsor2 cosponsors · 2 D
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Re-Valuing Anti-Microbial Products Act of 2018 or the REVAMP Act
What it does: CRS summary · Introduced in House · Jun 28, 2018
Re-Valuing Anti-Microbial Products Act of 2018 or the REVAMP Act
This bill amends the Federal Food, Drug, and Cosmetic Act to provide for an award of 12 additional months of market exclusivity to a drug manufacturer for a drug designated as a "priority antimicrobial product." (A priority antimicrobial product is intended to treat or prevent a disease attributable to a multi-drug resistant bacterial or fungal pathogen for which there is a critical unmet medical need.)
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: REVAMP Act
Also known as: Re-Valuing Anti-Microbial Products Act of 2018
Latest action (Jun 28, 2018): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jun 28, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.